Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
MONTELUKAST SODIUM
Pensa Pharma AB
MONTELUKAST SODIUM
5 Milligram
Tablets Chewable
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
PACKAGE LEAFLET: INFORMATION FOR THE USER Montelukast Pensa 5 mg chewable tablets Montelukast READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, please ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Montelukast Pensa is and what it is used for 2. What you need to know before you take Montelukast Pensa 3. How to take Montelukast Pensa 4. Possible side effects 5. How to store Montelukast Pensa 6. Contents of the pack and other information 1. WHAT MONTELUKAST PENSA IS AND WHAT IT IS USED FOR Montelukast Pensa is a leukotriene receptor antagonist that blocks substances called leukotrienes. Leukotrienes cause narrowing and swelling of airways in the lungs. By blocking leukotrienes, Montelukast Pensa improves asthma symptoms and helps control asthma. Your doctor has prescribed Montelukast Pensa to treat asthma, preventing your asthma symptoms during the day and night. - Montelukast Pensa is used for the treatment of 6 – 14 years old patients who are not adequately controlled on their medication and need additional therapy. - Montelukast Pensa may also be used as an alternative treatment to inhaled corticosteroids for 6 – 14 years old patients who have not recently taken oral corticosteroids for their asthma and have shown that they are unable to use inhaled corticosteroids. - Montelukast Pensa also helps prevent the narrowing of airways triggered by exercise. Your doctor will determi Citiți documentul complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Montelukast Pensa 5mg Chewable Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains 5.20 mg of montelukast sodium, which is equivalent to 5 mg of montelukast. Excipients with known effect: Each chewable tablet contains 3.00 mg of aspartame. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Chewable tablet. The 5 mg chewable tablets are pink and biconvex with the code M5 engraved on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Montelukast Pensa 5 mg chewable tablets is indicated in children and adolescents from 6 to 14 years of age for the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom 'as-needed' short-acting -agonists provide inadequate clinical control of asthma. Montelukast Pensa 5 mg chewable tablets may also be an alternative treatment option to low-dose inhaled corticosteroids for 6 to 14 years old patients with mild persistent asthma who do not have a recent history of serious asthma attacks that required oral corticosteroid use, and who have demonstrated that they are not capable of using inhaled corticosteroids (see section 4.2). Montelukast Pensa 5 mg chewable tablets is also indicated in the prophylaxis of asthma for 6 to 14 years old patients in which the predominant component is exercise-induced bronchoconstriction. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: The dosage for paediatric patients 6-14 years of age is one 5 mg chewable tablet daily to be taken in the evening. If taken in connection with food, Montelukast Pensa should be taken 1 hour before or 2 hours after food. No dosage adjustment wi Citiți documentul complet